Brief: Sigilon Therapeutics Inc - On Feb 18, Board Appointed Josias Fantato De Pontes As The Co's Acting Chief Financial Officer And Treasurer
22/02/2022 22:34
Feb 22 (Reuters) - Sigilon Therapeutics Inc SGTX.O :
* SIGILON THERAPEUTICS INC - ON FEB 18, BOARD APPOINTED
JOSIAS
FANTATO DE PONTES AS THE CO'S ACTING CHIEF FINANCIAL OFFICER AND
TREASURER
Source: [https://bit.ly/3LT9Hww]
Further company coverage: SGTX.O
Recent news on Sigilon Therapeutics
See all newsSigilon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Sigilon Therapeutics Inc expected to post a loss of $4.71 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Micron, Greenbrier, Immunome
Sigilon jumps on Eli Lilly's buyout deal to expand diabetes treatments
U.S. STOCKS ON THE MOVE-Sigilon, Netflix, RenovoRx